Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever
Status:
RECRUITING
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
1. Primary Objective:
o To evaluate the efficacy of intravenous azithromycin compared with meropenem in the treatment of extensively drug-resistant (XDR) enteric fever.
2. Secondary Objectives:
* To evaluate the fever defervescence and Salmonella Typhi eradication
* To evaluate the cost-effectiveness of intravenous azithromycin versus meropenem in treating XDR enteric fever.
3. Exploratory Objectives:
* To evaluate the drug resistance against intravenous azithromycin versus in treating XDR enteric fever.